Canaloplasty: First day microhyphaema

Article

Potentially a predictive factor for surgical success.

In a prospective, non-randomized study, my colleagues and I evaluated predictive factors for success in canaloplasty.10 The study group included 47 primary open angle glaucoma (POAG) patients with a mean IOP before surgery of 26.8 mmHg ± 5.2 (SD). The mean followup time was 20.6 months ± 8.3 (SD). The mean IOP was 8.4 mmHg ± 4.2 (SD) 1 day after surgery and 12.7 mmHg ± 1.7 (SD) at 24 months.

In a post-hoc analysis, there was no difference between patients with microhyphaema, compared to those without microhyphaema in regard to age, preoperative IOP, glaucomatous damage, number of medications and even in regard to day 1 IOP. However, the lower the target IOP after surgery was defined, the greater the differences in the complete success rates were between the two groups. For instance, the complete success rate in the eyes with microhyphaema was 87% compared to 21% in non-microhyphaema eyes for a target IOP under 16 mmHg, whereas it was 97% versus 71% respectively, for a target IOP less than 21 mmHg. Of note, eyes without microhyphaema required more frequent and earlier laser goniopuncture than eyes with microhyphaema (p < 0.001).

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.